Controlled drug delivery ocular implants and methods of using same
US11253394B2 · kind B2 · utility
18Cited by
362References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 20, 2018 |
| Grant date | Feb 22, 2022 |
| Priority date | — |
| Expiry date | Aug 9, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61F2250/0067
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.